See Local News
Get Balanced News From Your U.S. State.
See Local News
See all locals

FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot

Posted on AllSides June 14th, 2024
From The Center
REUTERS/Andrew Kelly/File Photo

The U.S. health regulator has changed its strain recommendation for the 2024-25 COVID-19 vaccines, as it asked manufacturers to update the new shots to target the KP.2 variant, if feasible, instead of the JN.1 lineage it sought to target earlier.

The Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even as Moderna (MRNA.O) and Novavax (NVAX.O) — makers of two of the three COVID vaccines — submitted their applications to the agency for updating the fall 2024 season shots with the JN.1 strain.

Novavax had...

Read full story

More News about Public Health from the Left, Center and Right

From the Left

From the Center

From the Right